Clinical trial
An Open-label Study Evaluating the Maintenance of Clinical Effect in Adult…
NCT00246272 · Janssen-Ortho Inc., Canada, Industry · Completed
Key facts
| NCT number | NCT00246272 |
|---|---|
| Title | An Open-label Study Evaluating the Maintenance of Clinical Effect in Adult Schizophrenia Patients Switched From Risperidone Tablets to an Equivalent Dose of a Rapidly-dissolving Tablet Formulation of Risperdone |
| Official title | An Open-label Study Evaluating the Maintenance of Clinical Effect in Adults With Schizophrenia Switched From RISPERDAL® Tablets (Risperidone) to an Equivalent Dose of a Rapidly-dissolving Tablet Formulation of Risperdone |
| Lead sponsor | Janssen-Ortho Inc., Canada, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Schizophrenia |
| Intervention type | Drug |
| Interventions | risperidone |
| Enrollment | 82 |
| Start date | Oct 1, 2004 |
| Completion | May 1, 2006 |
| First posted | Oct 31, 2005 |
| Last update posted | Apr 27, 2010 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: